protein kinase C inhibitors (Mississippi State)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameprotein kinase C inhibitors (Mississippi State)
Drug Alias NamePKC inhibitors (Mississippi State)bis-indolemaleimide derivatives (Mississippi State)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsIschemiaInflammationDiabetes Mellitus +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMississippi State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMississippi State University
Active IndicationsN/A
Inactive IndicationsIschemiaInflammationDiabetes Mellitus +[6] 

Other Information

ATC CodeN/A
Related LinksN/A